Guide: Screening programmes: a short guide. Increase effectiveness, maximize benefits and minimize harm (European Union): Difference between revisions
From Beacon
m (Update categories.) |
No edit summary |
||
| Line 1: | Line 1: | ||
<span style="display:none">forpolicymakers</span> | <span style="display:none">forpolicymakers</span> | ||
<span style="display:none">europeanunion</span> | |||
Go back to [[European Union]] page | Go back to [[European Union]] page | ||
Revision as of 16:22, 2 December 2025
Go back to European Union page
Primary purpose: To provide guidance to policy-makers and public health leads in the WHO European Region on planning, designing, and implementing effective screening programs while considering evidence-based decision-making, quality assurance, and minimizing potential harm, costs, and burdens on the healthcare system.
Sponsor, manager or home institution: WHO Regional Office for Europe.
Type of information: screening.
Data level: european level.
Cancer areas of interest: C00-C97: All cancer types. Click here to learn more.
Access to information: Click here to access.